New study shows that the gene G6PC2 plays an important role in regulating glucagon, a hormone that raises blood sugar levels.

Glucagon prescriptions for severe hypoglycemia rose in Medicaid beneficiaries with the introduction of newer products but likely met only a fraction of the high-risk population’s needs.

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Biomedical researchers at Ohio University have received National Institutes of Health (NIH) funding to investigate the role ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...